AngioDynamics Says Rival Must Stay In $145M Damages Row
By David Matthews · September 19, 2018, 9:51 PM EDT
Medical device maker AngioDynamics Inc. pushed back Wednesday against a competitor's attempt to toss racketeering claims, arguing in Massachusetts federal court that the competitor is culpable in Biolitec AG's alleged scheme...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login